Spero Therapeutics (SPRO) Loses -9.32% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Portfolio Pulse from
Spero Therapeutics (SPRO) has experienced a -9.32% decline over the past four weeks. The stock is now in oversold territory, and Wall Street analysts are raising earnings estimates, suggesting a potential trend reversal.

December 17, 2024 | 12:45 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Spero Therapeutics (SPRO) has seen a significant decline of -9.32% over the past month. The stock is now considered oversold, and analysts are increasing their earnings estimates, indicating a potential trend reversal.
The stock's oversold status suggests that the selling pressure may have been overdone, and the increase in earnings estimates by analysts is a positive signal. These factors combined could lead to a rebound in SPRO's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100